Literature DB >> 10871818

Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma.

A Arican1, T Sengezer, M Bozdayi, H Bozkaya, E Uçgül, D Dinçol, O Uzunalimoğlu.   

Abstract

Several studies have reported that hepatitis-C virus may have a role in the development of non- Hodgkin's lymphoma. Hepatitis-G virus has hepatitis-C virus like characteristics. The possible association between hepatitis-G virus infection and non-Hodgkin's lymphoma is not clear. The aim of this study was to determine the prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma without blood transfusion. Forty-four patients with non-Hodgkin's lymphoma were enrolled in the study. Serum samples derived from the patients were tested for antibodies against hepatitis-C virus by ELISA. Hepatitis-G virus and hepatitis-C virus RNA were detected by reverse transcription-polymerase chain reaction. Only two of 44 patients (5%) with non-Hodgkin's lymphoma were positive for Anti- HCV and hepatitis C virus RNA. One patient had low grade non-Hodgkin's lymphoma with follicular mixed histopathology while the other had intermediate grade with diffuse large cell histopathology. Hepatitis-G virus infection was detected in none of the patients. We concluded that hepatitis-G virus does not seem to be in association with non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871818     DOI: 10.1007/BF02796207

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  25 in total

1.  The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma--a regional association?

Authors:  M D McColl; I O Singer; R C Tait; I R McNeil; R L Cumming; R B Hogg
Journal:  Leuk Lymphoma       Date:  1997-06

2.  Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma.

Authors:  E Zuckerman; T Zuckerman; A M Levine; D Douer; K Gutekunst; M Mizokami; D G Qian; M Velankar; B N Nathwani; T L Fong
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

3.  Prevalence of antibodies to hepatitis C virus in blood donors and risk groups in Istanbul, Turkey.

Authors:  O S Yenen; S Badur
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

4.  Clonal B cell expansions in patients with essential mixed cryoglobulinaemia.

Authors:  A Perl; P D Gorevic; D H Ryan; J J Condemi; R J Ruszkowski; G N Abraham
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

5.  HCV and non-Hodgkin lymphoma.

Authors:  P Pioltelli; G Zehender; G Monti; A Monteverde; M Galli
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

6.  Binding of hepatitis C virus to CD81.

Authors:  P Pileri; Y Uematsu; S Campagnoli; G Galli; F Falugi; R Petracca; A J Weiner; M Houghton; D Rosa; G Grandi; S Abrignani
Journal:  Science       Date:  1998-10-30       Impact factor: 47.728

7.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

8.  Isolation of novel virus-like sequences associated with human hepatitis.

Authors:  J N Simons; T P Leary; G J Dawson; T J Pilot-Matias; A S Muerhoff; G G Schlauder; S M Desai; I K Mushahwar
Journal:  Nat Med       Date:  1995-06       Impact factor: 53.440

9.  Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.

Authors:  H Hartmann; P Schott; F Polzien; S Mihm; A Uy; U Kaboth; I Pardowitz; G Ramadori
Journal:  Z Gastroenterol       Date:  1995-11       Impact factor: 2.000

10.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

View more
  6 in total

1.  Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.

Authors:  Lenka Goldman; Sameera Ezzat; Nadia Mokhtar; Amany Abdel-Hamid; Nathan Fowler; Iman Gouda; Soheir Abdel Latif Eissa; Mohamed Abdel-Hamid; Christopher A Loffredo
Journal:  Cancer Causes Control       Date:  2009-03-05       Impact factor: 2.506

2.  No association between lymphoma and hepatitis C virus.

Authors:  Agustin Avilés; Leticia Valdez; José Halabe; Natividad Neri; Haiko Nellen; Judith Huerta-Guzmán; M Jesús Nambo
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Hepatitis G virus infection in Egyptian children with chronic renal failure (single centre study).

Authors:  Ayman Mohammad Hammad; Mohammad Hosam El Deen Zaghloul
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-12-16       Impact factor: 3.944

Review 4.  Hepatitis G virus.

Authors:  Vasiliy Ivanovich Reshetnyak; Tatiana Igorevna Karlovich; Ljudmila Urievna Ilchenko
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

Review 5.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

6.  Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma.

Authors:  Z Salem; N Nuwaiyri-Salti; F Ramlawi; S Ramia
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.